January 19, 2017
March 17, 2016
Professor Carl Figdor has been appointed as Visiting Professor at this Chair of Oncology for 2016. He has published many important studies in the field of tumor immunology and his accomplishments have been internationally recognized.
The objective of attracting visiting professors is to cement Maastricht’s oncology research with highly recognized national and international research teams, which raises cancer research and finally cancer treatment to a higher level. The TEFAF Oncology Chair provides a strong impuls to achieve such (inter)national cooperations.
Click here for the interview in Observant (only in Dutch).
Programme Master Class
Photographic impression Master Class
Photographic impression Inauguration
Video: welcome by Prof. F. Ramaekers
Video: lecture “The dichotomy of tumor-promoting and tumor-antagonizing immune responses” by Prof. D. Hanahan
Video: lecture “Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment” by Prof. dr. J. de Vries
Lecture “The immunoregulatory role of neutrophils in disease progression and therapy resistance of melanoma” by Prof. dr. T. Tüting (no video available)
Video: lecture “Natural killer cells: the secret weapon in dendritic cell vaccination strategies” by dr. W. Germeraad
Video: lecture “Tryptophan-degrading enzymes in tumoral immune resistance” by Prof. dr. B. van den Eynde
Video: lecture "Targeting or reprogramming tumor macrophages for anticancer therapy" by dr. M. de Palma
Video: lecture “Metabolic communication and competition: why T cells fight and cooperate in tumors” by dr. P. Ho
Video: inaugural lecture “Making of the immune system: a glimpse into the future” by Prof. C. Figdor
November 17, 2015
On November 17th 11.00-17.00 hrs Co Greepzaal UNS 60, the next GROW Master Class was organised.
In this Master Class 7 young GROW researchers (Junior Staff, Post Docs or PhD-Students in their 3rd or 4th year) presented and discussed their research in front of a panel of distinguished experts; Prof. dr. Jim Herman, Prof. dr. John Trowsdale,d Prof. dr. J. Geraedts and Prof. dr. P. Steijlen.
Please click here for the programme.
March 20, 2015
TEFAF Oncology chair holder: prof.dr. Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (Institut Suisse de Recherche Experimentale sur le Cancer ISREC) and Professor of Molecular Oncology in the SChool of Life Sciences at the Swiss Federal Institute of Technology Lausanne.
- Master Class 'Hallmarks of Cancer'
- Inauguration: "The daunting complexity of cancer: Understanding the battlefield is a step toward winning the war"